|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.076 +0.003 (+4.110%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 36,581 | -49.921% | 152,299 | 198,032 | 323,334 | 291,415 |
| Cost of Sales | (23,033) | -43.970% | (89,495) | (142,036) | (195,706) | (176,451) |
| Gross Profit | 13,548 | -57.582% | 62,804 | 55,996 | 127,628 | 114,964 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (1,066) | (166) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 36,197 | -- | (88,366) | (272,585) | (199,183) | (122,970) | |
| Taxation | (11) | -- | 326 | 16 | (3,473) | (971) | |
| Profit / (Loss) from Discontinued Operations | (8,132) | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (16,811) | -- | (67) | 3,630 | 4,591 | 50,993 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 11,243 | -- | (88,107) | (268,939) | (198,065) | (72,948) | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | 4,353 | -1.605% | 10,026 | 7,292 | 21,553 | 16,970 |
| Depreciation & Amortisation | 5,522 | -67.798% | 29,476 | 36,585 | 33,138 | 22,700 |
| Directors' Emoluments | -- | -- | 7,180 | 7,022 | 7,473 | 7,195 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Disclaimer | Disclaimer | Unqualified (Modified Report) | Disclaimer |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 0.400 | -- | -3.140 | -9.580 | -7.060 | -2.610 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.018) | 0.001 | (0.009) | (0.019) |
| NBV per share ($) | (0.023) | -- | (0.030) | 0.000 | 0.094 | 0.167 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 11,243 |
| %Change | -- |
| EPS / (LPS) | HKD 0.004 |
| NBV Per Share ($) | HKD -0.023 |